Status:
COMPLETED
Clinical Determinants of Disease Progression in Patients With Limb Girdle Muscular Distrophy Type 2E
Lead Sponsor:
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Conditions:
LGMD2E
Eligibility:
All Genders
3+ years
Brief Summary
A retrospective observational study that will enable us to collect retrospective data from the clinical records of LGMD 2E patients in order to highlight any possible correlation between: * clinical ...
Detailed Description
Retrospective observational study. Retrospective data from clinical charts of patients affected by LGMD 2E will be collected after the subscription of informed consent.Data considered will include any...
Eligibility Criteria
Inclusion
- Gene based diagnosis of LGMD 2E
- Subscription of informed consent when applicable
Exclusion
- Lacking gene based diagnosis of LGMD 2E
- Lacking subscription of informed consent when applicable
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT04509609
Start Date
June 1 2020
End Date
September 30 2021
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, Italy, 20122